LISTERINE AND CHECK-UP "AT RISK" OF REGULATORY ACTION FOR ANTI-PLAQUE, GINGIVITIS CLAIMS, FDA TELLS MARKETERS; LETTERS TO OTHER FIRMS TO FOLLOW